Nifty
Sensex
:
:
24231.85
77537.72
153.55 (0.64%)
628.04 (0.82%)

Pharmaceuticals & Drugs

Rating :
67/99

BSE: 506919 | NSE: MAKERSL

173.78
20-Aug-2026
  • Open
  • High
  • Low
  • Previous Close
  •  168.72
  •  183.99
  •  168.72
  •  168.72
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  6660
  •  1178879.09
  •  183.99
  •  150

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 102.70
  • 30.03
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 106.83
  • N/A
  • 1.32

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 61.27%
  • 1.63%
  • 31.72%
  • FII
  • DII
  • Others
  • 0%
  • 0.00%
  • 5.38%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -1.43
  • 2.02
  • 10.43

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -17.31
  • -4.70
  • 67.60

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -13.95
  • -37.22

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.89
  • 8.89
  • 8.75

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 1.25
  • 1.26
  • 1.21

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 11.59
  • 11.59
  • 14.00

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Jun 26
Jun 25
Var%
Mar 26
Mar 25
Var%
Dec 25
Dec 24
Var%
Sep 25
Sep 24
Var%
Net Sales
42.77
35.00
22.20%
35.75
33.90
5.46%
35.67
27.69
28.82%
34.17
29.57
15.56%
Expenses
35.81
31.99
11.94%
30.48
30.82
-1.10%
31.50
26.38
19.41%
31.89
27.38
16.47%
EBITDA
6.96
3.01
131.23%
5.27
3.08
71.10%
4.17
1.31
218.32%
2.29
2.19
4.57%
EBIDTM
16.28%
8.61%
14.75%
9.10%
11.68%
4.72%
6.69%
7.40%
Other Income
0.61
0.27
125.93%
0.76
0.12
533.33%
0.33
0.88
-62.50%
0.36
10.51
-96.57%
Interest
0.15
0.18
-16.67%
0.17
0.18
-5.56%
0.20
0.19
5.26%
0.22
0.43
-48.84%
Depreciation
1.13
1.12
0.89%
1.13
0.90
25.56%
1.14
1.31
-12.98%
1.13
1.29
-12.40%
PBT
6.29
1.98
217.68%
4.74
2.11
124.64%
3.15
0.68
363.24%
1.29
11.09
-88.37%
Tax
1.70
0.69
146.38%
1.17
0.53
120.75%
0.88
0.41
114.63%
0.55
1.33
-58.65%
PAT
4.60
1.28
259.38%
3.56
1.58
125.32%
2.27
0.27
740.74%
0.75
9.76
-92.32%
PATM
10.75%
3.67%
9.96%
4.67%
6.36%
0.98%
2.18%
33.00%
EPS
2.55
0.74
244.59%
1.85
-0.08
-
1.59
-0.50
-
-0.20
14.94
-

Annual Results

Standalone Figures in Rs. Crores /

Consolidated
Description
TTM
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Net Sales
148.36
140.59
120.75
104.39
101.28
127.20
68.64
Net Sales Growth
17.60%
16.43%
15.67%
3.07%
-20.38%
85.31%
 
Cost Of Goods Sold
66.87
63.56
52.21
51.94
39.07
50.20
27.59
Gross Profit
81.49
77.03
68.54
52.45
62.20
77.00
41.06
GP Margin
54.92%
54.79%
56.76%
50.24%
61.41%
60.53%
59.82%
Total Expenditure
129.68
125.78
112.36
103.27
97.96
108.36
60.52
Power & Fuel Cost
-
10.19
10.88
11.32
12.70
8.78
5.55
% Of Sales
-
7.25%
9.01%
10.84%
12.54%
6.90%
8.09%
Employee Cost
-
15.59
14.05
13.94
11.73
12.51
8.71
% Of Sales
-
11.09%
11.64%
13.35%
11.58%
9.83%
12.69%
Manufacturing Exp.
-
28.42
27.99
19.14
28.56
29.60
12.68
% Of Sales
-
20.21%
23.18%
18.34%
28.20%
23.27%
18.47%
General & Admin Exp.
-
4.48
3.46
3.17
2.88
2.77
2.20
% Of Sales
-
3.19%
2.87%
3.04%
2.84%
2.18%
3.21%
Selling & Distn. Exp.
-
3.06
2.68
2.95
2.01
3.70
2.45
% Of Sales
-
2.18%
2.22%
2.83%
1.98%
2.91%
3.57%
Miscellaneous Exp.
-
0.49
1.10
0.82
0.98
0.81
1.35
% Of Sales
-
0.35%
0.91%
0.79%
0.97%
0.64%
1.97%
EBITDA
18.69
14.81
8.39
1.12
3.32
18.84
8.12
EBITDA Margin
12.60%
10.53%
6.95%
1.07%
3.28%
14.81%
11.83%
Other Income
2.06
1.71
11.89
1.53
2.28
2.60
0.96
Interest
0.74
0.85
1.29
2.02
2.20
1.74
1.76
Depreciation
4.53
4.53
4.79
4.54
4.24
4.02
4.61
PBT
15.47
11.15
14.20
-3.92
-0.84
15.68
2.70
Tax
4.30
3.29
2.50
0.89
1.35
3.97
1.36
Tax Rate
27.80%
29.51%
18.64%
-22.70%
-160.71%
25.30%
50.37%
PAT
11.18
2.35
7.49
-6.26
-4.75
4.98
-0.33
PAT before Minority Interest
3.43
7.86
10.91
-4.81
-2.19
11.72
1.35
Minority Interest
-7.75
-5.51
-3.42
-1.45
-2.56
-6.74
-1.68
PAT Margin
7.54%
1.67%
6.20%
-6.00%
-4.69%
3.92%
-0.48%
PAT Growth
-13.27%
-68.62%
-
-
-
-
 
EPS
18.95
3.98
12.69
-10.61
-8.05
8.44
-0.56

Results Balance Sheet

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Shareholder's Funds
72.92
70.51
63.05
69.20
59.58
54.13
Share Capital
5.90
5.90
5.90
5.90
4.92
4.92
Total Reserves
67.02
64.61
57.15
63.30
54.66
49.21
Non-Current Liabilities
10.12
11.56
19.75
15.08
13.23
16.50
Secured Loans
1.03
2.06
3.08
2.32
2.69
5.53
Unsecured Loans
0.00
0.00
6.00
2.00
0.00
0.00
Long Term Provisions
0.42
0.27
0.25
0.27
0.43
0.38
Current Liabilities
34.02
21.20
37.17
27.54
33.01
33.12
Trade Payables
19.67
11.70
16.70
10.14
5.46
14.53
Other Current Liabilities
9.77
7.88
11.93
10.99
13.79
8.94
Short Term Borrowings
2.70
0.30
7.19
4.55
11.67
6.32
Short Term Provisions
1.88
1.33
1.34
1.85
2.09
3.34
Total Liabilities
166.61
147.96
161.26
152.29
144.33
136.19
Net Block
70.54
74.15
86.57
84.52
68.30
71.39
Gross Block
120.12
119.35
135.94
129.77
109.97
81.94
Accumulated Depreciation
49.58
45.19
49.38
45.25
41.67
10.55
Non Current Assets
79.67
79.68
91.45
89.04
81.42
75.15
Capital Work in Progress
3.73
0.59
0.32
0.49
9.38
0.16
Non Current Investment
0.15
0.14
0.12
0.08
0.22
1.21
Long Term Loans & Adv.
5.20
4.68
4.39
3.91
2.99
1.82
Other Non Current Assets
0.05
0.11
0.06
0.05
0.53
0.56
Current Assets
86.95
68.27
69.80
63.25
62.91
61.04
Current Investments
11.57
0.00
2.81
0.00
0.00
0.75
Inventories
44.94
34.04
33.80
31.32
23.84
27.47
Sundry Debtors
19.86
28.04
19.89
19.87
13.55
16.61
Cash & Bank
0.63
0.65
2.23
4.37
8.67
6.22
Other Current Assets
9.94
1.26
1.02
0.88
16.84
9.99
Short Term Loans & Adv.
8.64
4.29
10.04
6.81
13.00
1.40
Net Current Assets
52.93
47.07
32.63
35.71
29.90
27.92
Total Assets
166.62
147.95
161.25
152.29
144.33
136.19

Cash Flow

Standalone Figures in Rs. Crores /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Cash From Operating Activity
14.29
-4.08
0.84
-8.62
18.50
0.00
PBT
11.15
13.41
-3.92
-0.84
15.69
0.00
Adjustment
4.84
-3.89
5.79
5.65
5.21
0.00
Changes in Working Capital
1.62
-11.20
0.74
-10.96
3.23
0.00
Cash after chg. in Working capital
17.61
-1.68
2.62
-6.15
24.13
0.00
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-3.32
-2.40
-1.78
-2.47
-5.63
0.00
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-14.69
19.75
-6.89
1.25
-21.79
0.00
Net Fixed Assets
-0.33
10.42
-1.94
-3.46
-9.83
Net Investments
-0.01
-0.03
-0.04
0.03
1.11
Others
-14.35
9.36
-4.91
4.68
-13.07
Cash from Financing Activity
0.35
-15.84
5.74
5.78
0.33
0.00
Net Cash Inflow / Outflow
-0.05
-0.17
-0.31
-1.59
-2.96
0.00
Opening Cash & Equivalents
0.24
0.41
0.72
2.31
5.27
0.00
Closing Cash & Equivalent
0.20
0.24
0.41
0.72
2.31
0.00

Financial Ratios

Standalone /

Consolidated
Description
Mar 26
Mar 25
Mar 24
Mar 23
Mar 22
Mar 21
Book Value (Rs.)
123.59
119.49
106.85
117.28
121.17
105.62
ROA
5.00%
7.06%
-3.07%
-1.48%
8.35%
0.99%
ROE
10.96%
16.33%
-7.28%
-3.40%
20.61%
2.49%
ROCE
15.83%
19.01%
-2.36%
1.72%
24.00%
6.53%
Fixed Asset Turnover
1.17
0.95
0.79
0.84
1.33
0.84
Receivable days
62.18
72.44
69.51
60.23
43.28
88.31
Inventory Days
102.52
102.53
113.86
99.41
73.62
146.06
Payable days
90.08
99.28
94.32
72.86
72.68
192.25
Cash Conversion Cycle
74.62
75.69
89.06
86.77
44.22
42.12
Total Debt/Equity
0.07
0.05
0.28
0.17
0.29
0.26
Interest Cover
14.11
11.42
-0.94
0.62
10.03
2.53

News Update:


  • Makers Laboratories - Quarterly Results
    8th Aug 2026, 00:00 AM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.